Target intelligence / Profile preview

Gut Ecosystem and Host Cellular Interfaces

Molecular classification
Other
01

Overview

The Gut Ecosystem and Host Cellular Interfaces represents the complex biological boundary where the intestinal microbiota interacts with host epithelial, immune, and neural cells. This interface is fundamental to human health, serving as a primary site for nutrient absorption, immune system priming, and protection against opportunistic pathogens (Belkaid & Hand, 2014, Science). It involves a multi-layered system including the mucus layer, the epithelial monolayer, and the underlying lamina propria containing various immune cell populations. Dysregulation of this interface, often characterized by increased permeability or microbial dysbiosis, is a hallmark of numerous diseases, including inflammatory bowel disease (IBD), obesity, and metabolic syndrome (Fan & Pedersen, 2021, Nature Reviews Microbiology). Therapeutic interventions targeting this system range from microbial modulators like probiotics and fecal microbiota transplantation to biologics that reinforce barrier integrity or modulate mucosal immunity. Because it encompasses a vast array of molecular interactions rather than a single protein, it is categorized as a systemic interface rather than a discrete therapeutic target. Key molecular components within this interface include Toll-like receptors (TLRs) and G protein-coupled receptors (GPCRs) that sense microbial metabolites like short-chain fatty acids (Koh et al., 2016, Cell). Understanding this interface is crucial for developing precision medicine approaches that account for the symbiotic relationship between the host and its resident microbes.

Other names
Gut-microbiome-host axisIntestinal mucosal interfaceGut-host interfaceIntestinal barrier system
02

Mechanism of action

Modulation of microbial composition, enhancement of epithelial barrier integrity, and regulation of mucosal immune signaling.

03

Biological functions

Immune responseMetabolismBarrier functionSignal transductionNutrient absorption
04

Disease associations

Inflammatory bowel diseaseColorectal cancerMetabolic syndromeObesityType 2 diabetesAutoimmune disease
05

Safety considerations

Systemic infectionDysbiosisImmunogenicityOff-target metabolic effectsTransfer of antibiotic resistance
06

Interacting drugs

Fecal microbiota transplantation

5 more in the full profile.

07

Biomarkers

Fecal calprotectinSerum zonulinShort-chain fatty acids (SCFAs)Microbial diversity index

Beyond the preview

Go deeper on Gut Ecosystem and Host Cellular Interfaces.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut Ecosystem and Host Cellular Interfaces.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call